Drug development is an intricate process, with CMC challenges often being a key contributor to high attrition rates. Certara’s Chemistry, Manufacturing & Controls (CMC) Services address these complexities by focusing on the physicochemical properties of molecules early in development. This approach reduces attrition risks and fortifies your pipeline for long-term success.
Certara’s CMC experts provide tailored support across all development phases, including preclinical, clinical, and post-market stages. Our services include regulatory strategy preparation, CDMO evaluation, gap assessments, and advanced modeling tools to optimize outcomes for both small and large molecules.
